150 related articles for article (PubMed ID: 29150959)
1. NONO ubiquitination is mediated by FBW7 and GSK3 β via a degron lost upon chromosomal rearrangement in cancer.
Alfano L; Caporaso A; Altieri A; Costa C; Forte IM; Iannuzzi CA; Barone D; Esposito L; Giordano A; Pentimalli F
J Cell Physiol; 2018 May; 233(5):4338-4344. PubMed ID: 29150959
[TBL] [Abstract][Full Text] [Related]
2. FBW7 regulates DNA interstrand cross-link repair by modulating FAAP20 degradation.
Wang J; Jo U; Joo SY; Kim H
Oncotarget; 2016 Jun; 7(24):35724-35740. PubMed ID: 27232758
[TBL] [Abstract][Full Text] [Related]
3. Stringent Control of NFE2L3 (Nuclear Factor, Erythroid 2-Like 3; NRF3) Protein Degradation by FBW7 (F-box/WD Repeat-containing Protein 7) and Glycogen Synthase Kinase 3 (GSK3).
Kannan MB; Dodard-Friedman I; Blank V
J Biol Chem; 2015 Oct; 290(43):26292-302. PubMed ID: 26306035
[TBL] [Abstract][Full Text] [Related]
4. GSK3β-SCFFBXW7α mediated phosphorylation and ubiquitination of IRF1 are required for its transcription-dependent turnover.
Garvin AJ; Khalaf AHA; Rettino A; Xicluna J; Butler L; Morris JR; Heery DM; Clarke NM
Nucleic Acids Res; 2019 May; 47(9):4476-4494. PubMed ID: 30854564
[TBL] [Abstract][Full Text] [Related]
5. Ubiquitin Ligase, Fbw7, Targets CDX2 for Degradation via Two Phosphodegron Motifs in a GSK3β-Dependent Manner.
Kumar Y; Shukla N; Thacker G; Kapoor I; Lochab S; Bhatt ML; Chattopadhyay N; Sanyal S; Trivedi AK
Mol Cancer Res; 2016 Nov; 14(11):1097-1109. PubMed ID: 27470268
[TBL] [Abstract][Full Text] [Related]
6. E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for Degradation.
Kumar Y; Kapoor I; Khan K; Thacker G; Khan MP; Shukla N; Kanaujiya JK; Sanyal S; Chattopadhyay N; Trivedi AK
J Biol Chem; 2015 Dec; 290(52):30975-87. PubMed ID: 26542806
[TBL] [Abstract][Full Text] [Related]
7. NONO regulates the intra-S-phase checkpoint in response to UV radiation.
Alfano L; Costa C; Caporaso A; Altieri A; Indovina P; Macaluso M; Giordano A; Pentimalli F
Oncogene; 2016 Feb; 35(5):567-76. PubMed ID: 25893301
[TBL] [Abstract][Full Text] [Related]
8. IGFBP-3 interacts with NONO and SFPQ in PARP-dependent DNA damage repair in triple-negative breast cancer.
de Silva HC; Lin MZ; Phillips L; Martin JL; Baxter RC
Cell Mol Life Sci; 2019 May; 76(10):2015-2030. PubMed ID: 30725116
[TBL] [Abstract][Full Text] [Related]
9. The F-box protein FBXL16 up-regulates the stability of C-MYC oncoprotein by antagonizing the activity of the F-box protein FBW7.
Morel M; Shah KN; Long W
J Biol Chem; 2020 Jun; 295(23):7970-7980. PubMed ID: 32345600
[TBL] [Abstract][Full Text] [Related]
10. Functional Defects From Endocrine Disease-Associated Mutations in HLXB9 and Its Interacting Partner, NONO.
Kharade SS; Parekh VI; Agarwal SK
Endocrinology; 2018 Feb; 159(2):1199-1212. PubMed ID: 29309627
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of FBW7α-dependent p53 degradation enhances p53's function as a tumor suppressor.
Tripathi V; Kaur E; Kharat SS; Hussain M; Damodaran AP; Kulshrestha S; Sengupta S
J Biol Chem; 2019 Sep; 294(36):13224-13232. PubMed ID: 31346036
[TBL] [Abstract][Full Text] [Related]
12. Ets-1 promoter-associated noncoding RNA regulates the NONO/ERG/Ets-1 axis to drive gastric cancer progression.
Li D; Chen Y; Mei H; Jiao W; Song H; Ye L; Fang E; Wang X; Yang F; Huang K; Zheng L; Tong Q
Oncogene; 2018 Aug; 37(35):4871-4886. PubMed ID: 29773901
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of SCF ubiquitin ligases by engineered ubiquitin variants that target the Cul1 binding site on the Skp1-F-box interface.
Gorelik M; Orlicky S; Sartori MA; Tang X; Marcon E; Kurinov I; Greenblatt JF; Tyers M; Moffat J; Sicheri F; Sidhu SS
Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3527-32. PubMed ID: 26976582
[TBL] [Abstract][Full Text] [Related]
14. GSK3-SCF(FBXW7) targets JunB for degradation in G2 to preserve chromatid cohesion before anaphase.
Pérez-Benavente B; García JL; Rodríguez MS; Pineda-Lucena A; Piechaczyk M; Font de Mora J; Farràs R
Oncogene; 2013 Apr; 32(17):2189-99. PubMed ID: 22710716
[TBL] [Abstract][Full Text] [Related]
15. Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma.
Clark J; Lu YJ; Sidhar SK; Parker C; Gill S; Smedley D; Hamoudi R; Linehan WM; Shipley J; Cooper CS
Oncogene; 1997 Oct; 15(18):2233-9. PubMed ID: 9393982
[TBL] [Abstract][Full Text] [Related]
16. Protocadherin 19 (PCDH19) interacts with paraspeckle protein NONO to co-regulate gene expression with estrogen receptor alpha (ERα).
Pham DH; Tan CC; Homan CC; Kolc KL; Corbett MA; McAninch D; Fox AH; Thomas PQ; Kumar R; Gecz J
Hum Mol Genet; 2017 Jun; 26(11):2042-2052. PubMed ID: 28334947
[TBL] [Abstract][Full Text] [Related]
17. The ubiquitin ligase SCF
Song N; Cao C; Tang Y; Bi L; Jiang Y; Zhou Y; Song X; Liu L; Ge W
J Cell Physiol; 2018 Mar; 233(3):2366-2377. PubMed ID: 28722108
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of NONO induces apoptosis, suppressing growth and invasion in esophageal squamous cell carcinoma.
Cheng R; Zhu S; Guo S; Min L; Xing J; Guo Q; Li P; Zhang S
Oncol Rep; 2018 Jun; 39(6):2575-2583. PubMed ID: 29620226
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar targeting of the fbw7 ubiquitin ligase by a pseudosubstrate and glycogen synthase kinase 3.
Welcker M; Larimore EA; Frappier L; Clurman BE
Mol Cell Biol; 2011 Mar; 31(6):1214-24. PubMed ID: 21220517
[TBL] [Abstract][Full Text] [Related]
20. Physiological functions of FBW7 in cancer and metabolism.
Shimizu K; Nihira NT; Inuzuka H; Wei W
Cell Signal; 2018 Jun; 46():15-22. PubMed ID: 29474981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
